CE‐MS and related techniques as a valuable tool in tumor biomarkers research
- 26 March 2010
- journal article
- review article
- Published by Wiley in Electrophoresis
- Vol. 31 (7), 1214-1226
- https://doi.org/10.1002/elps.200900671
Abstract
Cancer has been a disease of great concern because it is the second main cause of death in the world. Cures for most cancer pathologies have not yet been found, and an accurate and early diagnosis is essential for successful treatment. Therefore, research on tumor biomarkers has noticeably increased in recent years. The determination of such biomolecules, together with the routinely used laboratory exams for cancer diagnosis, would constitute a more reliable approach, known as systems biology. The “omics” era has corroborated in such investigations since the development of new technologies has arisen along with it. One of the techniques applied to the investigation of tumor biomarkers is CE, and the increasing applications of CE‐MS in this field are also observed. This review covers the published literature on tumor biomarker investigations by CE‐MS and related techniques, mostly within the last decade, but not limited to it. For didactic reasons this review is divided into the tumor biomarkers chemical classes, namely, proteins and related molecules, DNA adducts and modified nucleosides.Keywords
This publication has 87 references indexed in Scilit:
- The role of capillary electrophoresis–mass spectrometry to proteome analysis and biomarker discoveryJournal of Chromatography B, 2009
- DNA sequencing by CEElectrophoresis, 2009
- CE MALDI-TOF/TOF MS for multiplexed quantification of proteins in human ventricular cerebrospinal fluidElectrophoresis, 2009
- Capillary electrophoresis–mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: An update of recent developmentsMass Spectrometry Reviews, 2008
- The cancer secretome: a reservoir of biomarkersJournal of Translational Medicine, 2008
- CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnosticsProteomics – Clinical Applications, 2008
- Discovery and validation of urinary biomarkers for prostate cancerProteomics – Clinical Applications, 2008
- Biomarkers and surrogate endpoints: Preferred definitions and conceptual frameworkClinical Pharmacology & Therapeutics, 2001
- Identification and Characterization of a Novel Benzo[a]pyrene-Derived DNA AdductBiochemical and Biophysical Research Communications, 2001
- Urinary nucleosidesMass Spectrometry Reviews, 1998